HER2+ endometrioid endometrial cancer possesses distinct molecular and immunologic features associated with a more active immune microenvironment and worse prognosis
Shaina F. Bruce, Sharon Wu, Jennifer R. Ribeiro, Alex Farrell, Matthew J. Oberley, Ira Winer, Britt K. Erickson, Tenley Klc, Nathaniel L. Jones, Premal H. Thaker, Matthew A. Powell
Dive into the research topics of 'HER2+ endometrioid endometrial cancer possesses distinct molecular and immunologic features associated with a more active immune microenvironment and worse prognosis'. Together they form a unique fingerprint.